Ultrasonography Guided Subacromial Sodium Hyaluronate Injection in Rotator Cuff Disease

Sponsor
Isfahan University of Medical Sciences (Other)
Overall Status
Unknown status
CT.gov ID
NCT01735058
Collaborator
(none)
48
1
2
10
4.8

Study Details

Study Description

Brief Summary

This study will be performed to examine the effect of ultrasound-guided subacromial sodium hyaluronate injection in patients with impingement syndrome without rotator cuff complete tear.

Condition or Disease Intervention/Treatment Phase
  • Drug: Sodium Hyaluronate
  • Drug: Normal saline
Phase 2/Phase 3

Detailed Description

Rotator cuff disease in particular is a common cause of shoulder pain and weakness and comprises a significant proportion of the musculoskeletal complaints presenting to primary care doctors. Ultrasound is a readily available and cheap modality for looking more specifically at the rotator cuff and surrounding structures. More recently, ultrasound guidance has become a commonly employed method to perform diagnostic or therapeutic interventions. Despite the long history and the fact that this is a common diagnosis made in clinical practice, the exact cause and best treatment for this condition still are being explored. Although there are a few high-quality studies demonstrating the efficacy of sodium hyaluronate injection for rotator cuff disease, this study will be performed to examine the effect of ultrasound-guided subacromial sodium hyaluronate injection in patients with impingement syndrome without rotator cuff complete tear.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Evaluating the Efficacy of Ultrasonography Guided Subacromial Sodium Hyaluronate Injection in the Treatment of Rotator Cuff Disease
Study Start Date :
Feb 1, 2012
Anticipated Primary Completion Date :
Dec 1, 2012
Anticipated Study Completion Date :
Dec 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Sodium hyaluronate

Ultrasound guided injection of sodium hyaluronate

Drug: Sodium Hyaluronate
Ultrasound guided injection of sodium hyaluronate; Fermathron ™, 20 mg/2ml of Sodium Hyaluronate, 3 weekly injections.

Placebo Comparator: Normal saline

Ultrasound guided injection of normal saline

Drug: Normal saline
Ultrasound guided injection of 0.9% normal sodium hyaluronate line solution, at 2 mL/syringe, 3 weekly injections.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in pain severity after 3 weeks. [Up to 3 weeks]

    The pain score (100 mm Visual Analogue Score ) is evaluated before the first injection and one week after each injection up to 3rd week.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age >= 18 years

  • subacromial impingement syndrome

  • without a complete tear of rotator cuff

  • willingness to participate

Exclusion Criteria:
  • had any rheumatic disease, glenohumeral osteoarthritis, full-thickness rotator cuff tears, fractures, diabetes mellitus, infections, or tumors.

  • had hypersensitivity to hyaluronate

  • had participated in any other study within 6 months

  • had received a subacromial injection within 8 weeks

  • were pregnant or planned to become pregnant

  • were at risk of complications of intra-articular injections such as patients who received anti-coagulant drugs.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Rehabilitation, Alzahra Hospital Isfahan Iran, Islamic Republic of

Sponsors and Collaborators

  • Isfahan University of Medical Sciences

Investigators

  • Principal Investigator: Farnaz Dehghan, MD, Isfahan University of Medical Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Farnaz Dehgan Hosseinabadi, Principal Investigator, Isfahan University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01735058
Other Study ID Numbers:
  • 13912134
First Posted:
Nov 28, 2012
Last Update Posted:
Dec 4, 2012
Last Verified:
Dec 1, 2012
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 4, 2012